Published in J Infect Dis on December 23, 2013
Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics. Virology (2015) 0.83
Identification of a role for nucleolin in rabies virus infection. J Virol (2014) 0.83
Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses. J Mol Biol (2016) 0.76
The importance of immune evasion in the pathogenesis of rabies virus. J Vet Med Sci (2016) 0.76
Nuclear Trafficking of the Rabies Virus Interferon Antagonist P-Protein Is Regulated by an Importin-Binding Nuclear Localization Sequence in the C-Terminal Domain. PLoS One (2016) 0.76
Roles of the Rabies Virus Phosphoprotein Isoforms in Pathogenesis. J Virol (2016) 0.75
Large-Scale Phylogenomic Analysis Reveals the Complex Evolutionary History of Rabies Virus in Multiple Carnivore Hosts. PLoS Pathog (2016) 0.75
Subversion of the Immune Response by Rabies Virus. Viruses (2016) 0.75
Quantitative Analysis of the Microtubule Interaction of Rabies Virus P3 Protein: Roles in Immune Evasion and Pathogenesis. Sci Rep (2016) 0.75
Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci U S A (2006) 2.31
The origin and phylogeography of dog rabies virus. J Gen Virol (2008) 2.23
Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol (2003) 2.19
Evolutionary history and dynamics of dog rabies virus in western and central Africa. J Gen Virol (2009) 1.98
Genomic diversity and evolution of the lyssaviruses. PLoS One (2008) 1.98
Phylodynamics and human-mediated dispersal of a zoonotic virus. PLoS Pathog (2010) 1.83
Phi29 polymerase based random amplification of viral RNA as an alternative to random RT-PCR. BMC Mol Biol (2008) 1.81
Genetic constraints and the adaptive evolution of rabies virus in nature. Virology (2002) 1.65
Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol (2011) 1.64
European bat lyssavirus infection in Spanish bat populations. Emerg Infect Dis (2002) 1.63
Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J Virol (2005) 1.58
Phylogeography, population dynamics, and molecular evolution of European bat lyssaviruses. J Virol (2005) 1.51
A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis (2008) 1.45
Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication. J Virol (2009) 1.43
ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem (2003) 1.43
Herpesvirus capsid association with the nuclear pore complex and viral DNA release involve the nucleoporin CAN/Nup214 and the capsid protein pUL25. J Virol (2009) 1.42
Rabies, still neglected after 125 years of vaccination. PLoS Negl Trop Dis (2010) 1.36
The evolutionary history and dynamics of bat rabies virus. Infect Genet Evol (2006) 1.32
Serologic evidence of lyssavirus infection in bats, Cambodia. Emerg Infect Dis (2004) 1.31
Torsin mediates primary envelopment of large ribonucleoprotein granules at the nuclear envelope. Cell Rep (2013) 1.31
The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol (2007) 1.29
Rabies virus chaperone: identification of the phosphoprotein peptide that keeps nucleoprotein soluble and free from non-specific RNA. Virology (2006) 1.29
Rabies situation in Cambodia. PLoS Negl Trop Dis (2009) 1.28
Temporal dynamics of European bat Lyssavirus type 1 and survival of Myotis myotis bats in natural colonies. PLoS One (2007) 1.27
Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex. J Biol Chem (2003) 1.26
Massively parallel pathogen identification using high-density microarrays. Microb Biotechnol (2008) 1.26
Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies. J Interferon Cytokine Res (2006) 1.24
Renewed global partnerships and redesigned roadmaps for rabies prevention and control. Vet Med Int (2011) 1.22
Nucleocytoplasmic shuttling of the rabies virus P protein requires a nuclear localization signal and a CRM1-dependent nuclear export signal. Virology (2005) 1.20
Rabies virus transcription and replication. Adv Virus Res (2011) 1.19
Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein. J Virol (2006) 1.18
Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice. Virus Res (2005) 1.17
Imported episodic rabies increases patient demand for and physician delivery of antirabies prophylaxis. PLoS Negl Trop Dis (2010) 1.17
Modular organization of rabies virus phosphoprotein. J Mol Biol (2009) 1.17
Application of broad-spectrum resequencing microarray for genotyping rhabdoviruses. J Virol (2010) 1.16
European bat Lyssavirus transmission among cats, Europe. Emerg Infect Dis (2009) 1.15
Structure and function of the C-terminal domain of the polymerase cofactor of rabies virus. J Mol Biol (2004) 1.15
Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation. J Virol (2004) 1.14
Tuberous sclerosis complex and Myc coordinate the growth and division of Drosophila intestinal stem cells. J Cell Biol (2011) 1.13
Recent emergence and spread of an Arctic-related phylogenetic lineage of rabies virus in Nepal. PLoS Negl Trop Dis (2013) 1.12
Rhabdovirus matrix protein structures reveal a novel mode of self-association. PLoS Pathog (2008) 1.10
Solution structure of the C-terminal nucleoprotein-RNA binding domain of the vesicular stomatitis virus phosphoprotein. J Mol Biol (2008) 1.10
Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J Virol (2010) 1.10
A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl Trop Dis (2008) 1.08
More accurate insight into the incidence of human rabies in developing countries through validated laboratory techniques. PLoS Negl Trop Dis (2010) 1.07
Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response. J Cell Sci (2009) 1.06
Diarrhea-inducing activity of avian rotavirus NSP4 glycoproteins, which differ greatly from mammalian rotavirus NSP4 glycoproteins in deduced amino acid sequence in suckling mice. J Virol (2002) 1.05
Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J Virol (2010) 1.03
Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine (2010) 1.03
Control of rabies: epidemiology of rabies in Asia and development of new-generation vaccines for rabies. Comp Immunol Microbiol Infect Dis (2007) 1.02
Molecular epidemiology of rotaviruses among healthy calves in Japan: isolation of a novel bovine rotavirus bearing new P and G genotypes. Virus Res (2009) 1.01
Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice. Virus Res (2006) 1.01
Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells. J Virol (2006) 1.00
Molecular epidemiology of rabies in Indonesia. Virus Res (2008) 0.99
Hsp70 protein positively regulates rabies virus infection. J Virol (2012) 0.99
Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. Vaccine (2007) 0.97
Sequential analysis of nonstructural protein NSP4s derived from Group A avian rotaviruses. Virus Res (2002) 0.95
Risk for rabies importation from North Africa. Emerg Infect Dis (2011) 0.95
Subcellular trafficking in rhabdovirus infection and immune evasion: a novel target for therapeutics. Infect Disord Drug Targets (2012) 0.95
Lyssavirus detection and typing using pyrosequencing. J Clin Microbiol (2011) 0.94
Phenotypes of vesicular stomatitis virus mutants with mutations in the PSAP motif of the matrix protein. J Gen Virol (2011) 0.93
Whole genome characterization of new bovine rotavirus G21P[29] and G24P[33] strains provides evidence for interspecies transmission. J Gen Virol (2011) 0.92
First human rabies case in French Guiana, 2008: epidemiological investigation and control. PLoS Negl Trop Dis (2012) 0.92
Multigenic relation to the attenuation of rabies virus. Microbiol Immunol (2006) 0.92
Induction of nitric oxide synthase by rotavirus enterotoxin NSP4: implication for rotavirus pathogenicity. J Gen Virol (2007) 0.90
Dtorsin, the Drosophila ortholog of the early-onset dystonia TOR1A (DYT1), plays a novel role in dopamine metabolism. PLoS One (2011) 0.90
Genetic characterization of rabies field isolates from Thailand. Microbiol Immunol (2003) 0.90
The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling. J Virol (2013) 0.90
Epizootiological study of tick-borne encephalitis virus infection in Japan. J Vet Med Sci (2010) 0.90
Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness. J Virol (2013) 0.89
Human rabies encephalitis prevention and treatment: progress since Pasteur's discovery. Infect Disord Drug Targets (2011) 0.89
Sensitivity of rabies virus to type I interferon is determined by the phosphoprotein gene. Microbiol Immunol (2006) 0.88
A novel nuclear trafficking module regulates the nucleocytoplasmic localization of the rabies virus interferon antagonist, P protein. J Biol Chem (2012) 0.87
Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain. Microbiol Immunol (2005) 0.87
Roles of outer capsid proteins as determinants of pathogenicity and host range restriction of avian rotaviruses in a suckling mouse model. Virology (2003) 0.87